ClinicalTrials.Veeva

Menu

Robotic-assisted Training After Upper Arm Fracture (RASTA)

R

Robert Bosch Gesellschaft für Medizinische Forschung mbH

Status

Completed

Conditions

Shoulder Injury

Treatments

Other: Control Group
Other: Intervention Armeo®Spring

Study type

Interventional

Funder types

Other

Identifiers

NCT03100201
RASTA 2016

Details and patient eligibility

About

In this study, patients with upper arm fracture will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks on the injured arm in addition to conventional physio- and occupational therapy. The supportive treatment and execution of specific exercises on the Armeo®Spring should lead to improved recovery of function and mobility of the upper arm compared to conservatively treated patients.

Full description

60 Patients aged between 35 and 70 years with proximal humeral fracture and surgical treatment will be recruited in three different clinics in Germany and randomised into an intervention and a control group. Participants will be assessed before randomisation and followed up after completing an intervention period of 3 weeks and additionally after 3, 6 and 12 months. Baseline assessment will assess cognition (SOMC), level of pain in the affected arm, ability to work, gait speed (10m walk), disability of the arm, shoulder and hand (DASH), as well as the range of motion of the affected arm (goniometer measurement), visual acuity and motor function of orthopaedic patients (WMFT-O). Clinical follow up directly after intervention will assess disability of the arm, shoulder and hand (DASH), the range of motion and motor function (WMFT-O). Primary outcome parameter will be the DASH and secondary outcome parameter will be the WMFT-O. The long-term results will be assessed prospectively by a postal follow-up. All patients will receive conventional occupational- and physiotherapy. The intervention group will receive an additive robotic-assisted training using the Armeo®Spring robot for three weeks.

Enrollment

48 patients

Sex

All

Ages

35 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • surgical treatment of the shoulder joint after upper arm fracture classified as type AO 11
  • movement-stable fracture
  • Inclusion between the fourth and the seventh week after surgery

Exclusion criteria

  • limited cognition as defined by a score in Short-Orientation-Memory-Concentration Test (SOMC) less than 10 points
  • inadequate level of pain during movement of the affected shoulder joint (pain score >5 on a visual analogue pain scale)
  • strongly limited vision or hearing
  • heart failure (New York Heart Association stage III-IV) or COPD (Chronic Obstructive Pulmonary Disease) Gold stage III-IV
  • walking speed <0.8m/sec
  • isolated tuberculum majus fracture of the humerus (AO 11, A1)
  • fractures with involvement of the glenoid cavity
  • double fractures
  • injury of the plexus or the axillaris nerve

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

48 participants in 2 patient groups

Intervention Armeo®Spring
Active Comparator group
Description:
The intervention group will receive conventional occupational- and physiotherapy and an additive robotic-assisted training using the Armeo®Spring robot for three weeks.
Treatment:
Other: Intervention Armeo®Spring
Control group
Active Comparator group
Description:
The control group will receive conventional occupational- and physiotherapy.
Treatment:
Other: Control Group

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems